The team at Hogan Lovells (Paris) LLP is noted by clients for its ‘exceptional quality’, handling product liability claims, patent disputes, and preliminary injunctions. The group is also adept at advising on clinical trial issues, often acting in mandates with cross-jurisdictional elements. Mikael Salmela leads the team with his standout knowledge of M&A, supply issues, and data processing authorisations within the life sciences sector. The ’exceptional’ Charlotte Damiano is a regulatory expert noted for handling market access matters, with a strong focus on pricing and reimbursement work. Damiano often acts in cases concerning pharma product financial regulation.
Legal 500 Editorial commentary
- Profile
- Social
Testimonials
Collated independently by Legal 500 research team.
‘Expertise in life sciences and their mastery of different disciplines (price and reimbursement, regulations and Public Health Code, taxation, litigation and public law in particular).’
‘I greatly appreciate Charlotte Damiano's expertise in pharmaceutical taxation, market access and drug regulatory law. She has an excellent command of these subjects and communicates clearly and concisely, including on technical subjects and by anticipating the client's objectives and constraints, which makes discussions fluid and productive.’
‘The Hogan Lovells Life Sciences team in France is of exceptional quality with two leading experts, Charlotte Damiano and Mikael Salmela. Charlotte is a distinguished expert in regard to pricing and market access.’
‘The team has long and deep experience in the life sciences area. They are particularly strong in working with multinational clients.’
‘Charles-Henri Caron is particularly noteworthy for his skill, responsiveness and ability to help multinational companies navigate the French legal system.’
‘Charlotte Damiano is ultra competent, pragmatic and up to date with the latest trends and practices on the market. Always available and attentive to the needs of the client.’
‘Charles-Henri Caron defends us in complex and sensitive litigation (life sciences product liability). Always available and responsive, his expertise is excellent. He has our full trust, as does Emmanuelle Burkic.’
‘Charlotte Damiano is an exceptional partner in the field of market access specific to the pharmaceutical industry.’
Key clients
- Bristol Myers Squibb
- Merck & Co., Inc.
- MSD Vaccins
- Eli Lilly
- Icos Corporation
- Voluntis
- Medicrea
- Valneva
- GE Healthcare
- GERON
Work highlights
- Assisted Celgene with a major health data processing authorization request to the CNIL for an innovative drug treatment under a cohort authorization for temporary use in France, as well as with the launch and deployment of CAR-T products in France.
- Assisting Merck & Co., Inc. and its French subsidiary MSD Vaccins in the coordination and defence of product liability claims brought by French plaintiffs before the courts or before commissions for conciliation and indemnification, in relation to alleged adverse events of the vaccines Gardasil or Gardasil 9.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Mikael Salmela
Other key lawyers
Stanislas Roux-Vaillard; Charlotte Damiano; Charles-Henri Caron; Julie Schwartz; Emmanuelle Burkic